Renalytix plc Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Renalytix plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
  • Renalytix plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 106M shares, a 11.5% increase year-over-year.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 108M shares, a 31.6% increase from 2023.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.2M shares, a 11.3% increase from 2022.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 73.8M shares, a 3.29% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 106M +10.9M +11.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 108M +26M +31.6% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-30
Q1 2024 97.7M +12.1M +14.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 97.3M +22.4M +29.9% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 94.8M +20M +26.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 82.2M +8.37M +11.3% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-30
Q1 2023 85.6M +13.3M +18.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 74.9M +2.61M +3.61% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 74.8M +2.57M +3.56% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 73.8M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 72.3M +262K +0.36% Jan 1, 2022 Mar 31, 2022 6-K 2023-06-09
Q4 2021 72.3M Oct 1, 2021 Dec 31, 2021 6-K 2023-03-30
Q3 2021 72.2M Jul 1, 2021 Sep 30, 2021 6-K 2022-11-30
Q1 2021 72M Jan 1, 2021 Mar 31, 2021 6-K 2022-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.